- July 13, 2021
- Posted by: Stratford Team
- Category: Business
WEST LAFAYETTE, Ind. (Inside INdiana Business) — West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) has acquired the toxicology assets of MilliporeSigma in Massachusetts. Financial terms of the deal were not disclosed, but Inotiv says the deal comes as MilliporeSigma discontinues its genetic toxicology operations.
The acquired assets are from MilliporeSigma’s BioReliance portfolio and includes the company’s client list, standard operating procedures, stock cultures, and historic control data. Inotiv says it plans to offer employment to certain MilliporeSigma employees who may have otherwise been displaced.
Inotiv says the acquisition is designed to ensure continuity of services for existing clients.
“This transaction with MilliporeSigma adds genetic toxicology to our suite of internal capabilities,” said Robert Leasure, chief executive officer of Inotiv. “We now have assembled in-house all of the critical…
